growth/size/body
• weight is on average reduced by 25%
|
limbs/digits/tail
short limbs
(
J:173779
)
• short-limbed dwarfism, with mutants showing a reduction in entire limb size
|
muscle
• mutants exhibit muscle dystrophy
• large areas of dystrophic musculature are occupied by fat tissue
• muscle connective tissue shows increased proliferation at E14.5 and an increase in connective tissue in muscles is already seen at E16.5
• muscle fibers are thinned out at E16.5
|
• marker analysis indicates a defect in muscle formation at E13.5, with specific muscle primordial reduced in size or entirely missing; approximate 30% reduction in the m. triceps size and about 50% reduction in the m. gluteus maximus size of E13.5 embryos
• the m. latissimus dorsi appears smaller and shows rarefaction of muscle fibers
• distal muscle groups in the extremities are most affected, with some muscles completely missing, indicating that the muscle differentiation process is disturbed
|
• defect in myogenesis affecting the terminal differentiation of myoblasts between E12.5 and E14.5
|
• maker analysis indicates a severe disruption of myoblast terminal differentiation
|
• marker analysis indicates that migration and proliferation of pre-muscle cells at E11.5 are normal but increased proliferation of myoblasts in ventral muscle masses is seen
|
• muscles show a 20% increase in the number of fibers with cleft-like invaginations (split fibers)
• muscle fiber size appears more variable than in controls, however no overt muscle regeneration is seen
|
• total number of muscle fibers is reduced by 50% in the triceps
|
• weight of triceps muscle is reduced by more than 50%
|
• reduction in muscle size and mass
|
• generalized muscle fibrosis, characterized by expansion of collagen-rich connective tissue, and reduction in total number of muscle fibers
|
• in the force gauge pull test, mice show a dramatic reduction in muscle force
• satellite cells exhibit normal self-renewal but impaired differentiation as indicated by diminished myotube formatio
|
cellular
• maker analysis indicates a severe disruption of myoblast terminal differentiation
|
• marker analysis indicates that migration and proliferation of pre-muscle cells at E11.5 are normal but increased proliferation of myoblasts in ventral muscle masses is seen
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
neurofibromatosis 1 | DOID:0111253 |
OMIM:162200 |
J:173779 |